Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 7/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7614894 | 0.73 | PKM (0.51) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL11666542 | 0.69 | CRBN (0.52) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL4409228 | 0.69 | ALDH1A1 (0.41) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL3235869 | 0.67 | L3MBTL1 (0.53) | DUTCRBNL3MBTL1PKM | |
| SCHEMBL10618034 | 0.66 | PKM (0.51) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL572752 | 0.66 | CRBN (0.54) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL1913656 | 0.66 | — | — | |
| SCHEMBL5705360 | 0.65 | CRBN (0.47) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL6102943 | 0.64 | CRBN (0.56) | DUTCRBNL3MBTL1PKMDDB1 | |
| SCHEMBL426038 | 0.64 | CRBN (0.45) | DUTCRBNL3MBTL1PKMDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921304-B2 | Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin | SCIL PROTEINS GMBH | 2014-12-30 | — | — | US | claimed |
| EP-2367843-B1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2014-10-08 | — | — | EP | claimed |
| EP-2513138-B1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2014-10-01 | — | — | EP | claimed |
| US-20130011334-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | NAVIGO PROTEINS GMBH (DE) | 2013-01-10 | — | — | US | claimed |
| US-20120301393-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH | 2012-11-29 | — | — | US | claimed |
| EP-2513138-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | Scil Proteins GmbH (DE) | 2012-10-24 | — | — | EP | claimed |
| EP-2367843-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | Scil Proteins GmbH (DE) | 2011-09-28 | — | — | EP | claimed |
| WO-2011073208-A9 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2011-08-04 | — | — | WO | claimed |
| WO-2011073208-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2011-06-23 | — | — | WO | claimed |
| WO-2011073209-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2011-06-23 | — | — | WO | claimed |
| US-20150183846-A1 | HUMAN FUSION PROTEINS COMPRISING SINGLE CHAIN TNFALPHA AND TARGETING DOMAINS | SCIL PROTEINS GMBH (DE) | 2015-07-02 | — | — | US | disclosed |
| EP-2861616-A1 | HUMAN FUSION PROTEINS COMPRISING SINGLE CHAIN TNFALPHA AND TARGETING DOMAINS | Scil Proteins GmbH (DE) | 2015-04-22 | — | — | EP | disclosed |
| US-8921304-B2 | Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin | SCIL PROTEINS GMBH | 2014-12-30 | — | — | US | disclosed |
| EP-2367843-B1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2014-10-08 | — | — | EP | disclosed |
| EP-2513138-B1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2014-10-01 | — | — | EP | disclosed |
| EP-2513138-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | Scil Proteins GmbH (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2367843-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | Scil Proteins GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
| WO-2011073208-A9 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011073208-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073209-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | SCIL PROTEINS GMBH (DE) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120301393-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | STUB1, UBE4A, UBE2B | DUT 1855/4885CRBN 243/4885L3MBTL1 2622/4885 |
| US-20130011334-A1 | MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN | STUB1, UBE2B, UBE4A | DUT 2522/4885CRBN 206/4885L3MBTL1 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.